Medicine and Dentistry
Cystinosis
100%
Cysteamine
70%
Cystine
46%
Azoospermia
21%
Pediatrics
18%
Retrospective Study
14%
Calcineurin Inhibitor
14%
Testes
14%
Nephrotic Syndrome
14%
Phosphate Metabolism
14%
Podocyte
14%
Bartter Syndrome
14%
Gitelman Syndrome
14%
Disease
14%
Chronic Kidney Disease
14%
Kidney Tubule Disorder
13%
Renal Failure
13%
Growth Retardation
12%
Growth Hormone
11%
Pediatric Nephrology
9%
Kidney Function
9%
Cohort Analysis
8%
In Vitro
8%
Epididymis
8%
Semen Analysis
8%
Isotopes of Calcium
8%
Parathyroid Hormone
8%
Leukocyte
7%
Kidney Malformation
7%
Cross Sectional Study
7%
Limb
7%
Stem Cell
7%
Genetic Trait
7%
Atherosclerosis
7%
Halitosis
7%
Early Intervention
7%
Distal Renal Tubular Acidosis
7%
CLCNKB
7%
Growth Hormone Release
7%
Dent's Disease
7%
Cardiovascular Risk
7%
Fibroblast Growth Factor 23
7%
Patient with Type 1 Diabetes
7%
Insulin Dependent Diabetes Mellitus
7%
Lupus Nephritis
7%
Conception
7%
Prolactinoma
7%
Non Invasive Measurement
7%
Nephrogenic Diabetes Insipidus
7%
Blood Testis Barrier
7%
Keyphrases
Cysteamine
35%
Cystinosis
33%
Cystine
18%
Gene Variants
14%
Calcineurin Inhibitors
14%
Nephrotic Syndrome
14%
Podocyte
14%
Multicenter Retrospective Study
14%
Genotype
8%
Delayed-release Cysteamine
8%
Ipsilateral Renal Anomaly
7%
Obstructed Hemivagina
7%
Diabetes Insipidus
7%
Retrospective Cohort Study
7%
Early Intervention
7%
Fibroblast Growth Factor 23 (FGF23)
7%
Non-invasive Measurement
7%
Calcium-phosphorus Metabolism
7%
Type I Diabetes
7%
Hormone Homeostasis
7%
Animal Fertility
7%
Halitosis
7%
Cardiovascular Risk
7%
Single Center
7%
Flucloxacillin
7%
Cell Microvesicles
7%
Terminal Renal Failure
7%
Seoul National University
7%
Growth Retardation
7%
Tacrolimus
7%
Trough Level
7%
Immediate-release Cysteamine
7%
Human Dermal Microvascular Endothelial Cells (HDMECs)
7%
Endothelial Viability
7%
Nephropathic Cystinosis
7%
Type 1 Diabetes Mellitus (T1DM)
7%
Fanconi-Bickel Syndrome
7%
SLC34A1
7%
SLC34A3
7%
Cystagon
6%
Steroid-resistant Nephrotic Syndrome
6%
RP103
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cystinosis
85%
Cysteamine
81%
Cystine
28%
Fanconi Renotubular Syndrome
15%
Halitosis
14%
Delayed Release
11%
Azoospermia
10%
Carnitine
8%
Cohort Study
8%
Kidney Tubule Disorder
8%
Tacrolimus
7%
Growth Retardation
7%
Atherosclerosis
7%
Copper Deficiency
7%
Parathyroid Hormone
7%
Prolactinoma
7%
Bartter Syndrome
7%
Gitelman Syndrome
7%
Cross-Sectional Study
7%
Trough Level
7%
Growth Hormone
7%
Flucloxacillin
7%
Empagliflozin
7%
Syndrome
7%
Repurposing
7%
Sodium Glucose Cotransporter 2 Inhibitor
7%
Dimethyl Sulfide
6%
Disease
6%
End Stage Renal Disease
5%
